U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542262) titled 'Phase II Open-lable Single-center Clinical Study of the Efficacy and Safety of Low-dose Im... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07540936) titled 'Effects of an Online Yoga Program on Exercise Capacity and Quality of Life in Bronchiectas... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541352) titled 'The Hugo RAS Colorectal Collaborative' on March 20. Brief Summary: The Hugo RAS Colorecta... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542327) titled 'The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity' on April 14. B... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541170) titled 'A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choi... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541053) titled 'Low Fat-free Mass in Prognosis of People With Chronic Obstructive Pulmonary Disease' on Ap... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07543042) titled 'Evaluation of the Sedative Effect of Contextualized Music Listening on Patient Pain and An... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541703) titled 'Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541989) titled 'Pulsed-Field Ablation With/Without Electrogram Mapping' on April 13. Brief Summary: Pulse... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542678) titled 'Double-T - Improving Outcomes in High-risk 2nd Line Relapsed/Refractory Large B-Cell Lymph... Read More